v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Total Shareholders' Equity (Deficit)
Common Shares
Additional paid-in capital
Accumulated deficit and cumulative distributions
Non-controlling interests in third party ventures and attributable to preferred shareholders
Common shares, beginning balance (in shares) at Dec. 31, 2024     34,705,985      
Beginning balance at Dec. 31, 2024 $ 653,177 $ 650,797 $ 347 $ 659,755 $ (9,305) $ 2,380
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common shares issued (in shares) 7,885,619   7,885,619      
Common shares issued $ 159,830 159,830 $ 79 159,751    
Common shares repurchased (in shares) (292,879)   (292,879)      
Common shares repurchased $ (5,914) (5,914) $ (3) (5,911)    
Amortization of restricted share grants 39 39   39    
Offering costs $ (7,812) (7,812)   (7,812)    
Distribution reinvestment (in shares) 606,948   606,948      
Distribution reinvestment $ 12,299 12,299 $ 6 12,293    
Distributions declared on common shares (22,779) (22,779)     (22,779)  
Net income (loss) 10,916 10,920     10,920 (4)
Contributions to non-controlling interests 10,346         10,346
Distributions to non-controlling interests (50)         (50)
Allocation to redeemable common shares (174) (174)   (174)    
Allocation to redeemable non-controlling interests (10) (10)   (10)    
Common shares, ending balance (in shares) at Jun. 30, 2025     42,905,673      
Ending balance at Jun. 30, 2025 809,868 797,196 $ 429 817,931 (21,164) 12,672
Common shares, beginning balance (in shares) at Mar. 31, 2025     38,755,571      
Beginning balance at Mar. 31, 2025 $ 726,196 723,856 $ 388 737,914 (14,446) 2,340
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common shares issued (in shares) 4,039,943   4,039,943      
Common shares issued $ 81,961 81,961 $ 40 81,921    
Common shares repurchased (in shares) (214,994)   (214,994)      
Common shares repurchased $ (4,367) (4,367) $ (2) (4,365)    
Amortization of restricted share grants 20 20   20    
Offering costs $ (4,062) (4,062)   (4,062)    
Distribution reinvestment (in shares) 325,153   325,153      
Distribution reinvestment $ 6,599 6,599 $ 3 6,596    
Distributions declared on common shares (12,017) (12,017)     (12,017)  
Net income (loss) 5,293 5,299     5,299 (6)
Contributions to non-controlling interests 10,346         10,346
Distributions to non-controlling interests (8)         (8)
Allocation to redeemable common shares (88) (88)   (88)    
Allocation to redeemable non-controlling interests (5) (5)   (5)    
Common shares, ending balance (in shares) at Jun. 30, 2025     42,905,673      
Ending balance at Jun. 30, 2025 809,868 797,196 $ 429 817,931 (21,164) 12,672
Common shares, beginning balance (in shares) at Dec. 31, 2025     52,131,183      
Beginning balance at Dec. 31, 2025 $ 966,154 953,811 $ 521 997,431 (44,141) 12,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common shares issued (in shares) 17,501,952   17,501,952      
Common shares issued $ 366,068 366,068 $ 175 365,893    
Common shares repurchased (in shares) (816,308)   (816,308)      
Common shares repurchased $ (20,812) (20,812) $ (8) (20,804)    
Share class transfer (in shares)     (68)      
Amortization of restricted share grants 39 39   39    
Offering costs $ (17,763) (17,763)   (17,763)    
Distribution reinvestment (in shares) 1,176,843   1,176,843      
Distribution reinvestment $ 24,352 24,352 $ 12 24,340    
Distributions declared on common shares (44,543) (44,543)     (44,543)  
Net income (loss) (4,857) (4,847)     (4,847) (10)
Distributions to non-controlling interests (415)         (415)
Allocation to redeemable common shares (420) (420)   (420)    
Allocation to redeemable non-controlling interests (143) (143)   (143)    
Common shares, ending balance (in shares) at Jun. 30, 2026     69,993,602      
Ending balance at Jun. 30, 2026 1,267,660 1,255,742 $ 700 1,348,573 (93,531) 11,918
Common shares, beginning balance (in shares) at Mar. 31, 2026     59,385,429      
Beginning balance at Mar. 31, 2026 $ 1,084,904 1,072,768 $ 594 1,139,688 (67,514) 12,136
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common shares issued (in shares) 10,365,036   10,365,036      
Common shares issued $ 217,642 217,642 $ 104 217,538    
Common shares repurchased (in shares) (388,971)   (388,971)      
Common shares repurchased $ (10,619) (10,619) $ (4) (10,615)    
Share class transfer (in shares)     (56)      
Amortization of restricted share grants 19 19   19    
Offering costs $ (10,901) (10,901)   (10,901)    
Distribution reinvestment (in shares) 632,164   632,164      
Distribution reinvestment $ 13,143 13,143 $ 6 13,137    
Distributions declared on common shares (24,130) (24,130)     (24,130)  
Net income (loss) (1,892) (1,887)     (1,887) (5)
Distributions to non-controlling interests (213)         (213)
Allocation to redeemable common shares (168) (168)   (168)    
Allocation to redeemable non-controlling interests (125) (125)   (125)    
Common shares, ending balance (in shares) at Jun. 30, 2026     69,993,602      
Ending balance at Jun. 30, 2026 $ 1,267,660 $ 1,255,742 $ 700 $ 1,348,573 $ (93,531) $ 11,918